Tingdong Yu

1.3k total citations
44 papers, 749 citations indexed

About

Tingdong Yu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Tingdong Yu has authored 44 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Tingdong Yu's work include Pancreatic and Hepatic Oncology Research (12 papers), Cancer-related molecular mechanisms research (11 papers) and Ferroptosis and cancer prognosis (8 papers). Tingdong Yu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Cancer-related molecular mechanisms research (11 papers) and Ferroptosis and cancer prognosis (8 papers). Tingdong Yu collaborates with scholars based in China, Hong Kong and United States. Tingdong Yu's co-authors include Chuangye Han, Tao Peng, Xiwen Liao, Chengkun Yang, Xiangkun Wang, Guangzhi Zhu, Ketuan Huang, Wei Qin, Long Yu and Hao Su and has published in prestigious journals such as Gene, Journal of Cellular Physiology and Journal of Cellular Biochemistry.

In The Last Decade

Tingdong Yu

41 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tingdong Yu China 19 437 350 193 177 97 44 749
Shengguang Yuan China 15 469 1.1× 259 0.7× 231 1.2× 101 0.6× 88 0.9× 21 728
Romain Riscal United States 9 492 1.1× 356 1.0× 192 1.0× 118 0.7× 95 1.0× 12 822
Xiaoliang Xu China 18 528 1.2× 367 1.0× 134 0.7× 86 0.5× 102 1.1× 39 862
Danyu Du China 9 430 1.0× 324 0.9× 111 0.6× 103 0.6× 109 1.1× 13 698
Dinghua Yang China 16 485 1.1× 387 1.1× 398 2.1× 191 1.1× 80 0.8× 41 1000
Jiangting Hu United States 12 402 0.9× 186 0.5× 207 1.1× 118 0.7× 80 0.8× 21 769
Antoine L’Hermitte United States 8 391 0.9× 204 0.6× 151 0.8× 105 0.6× 131 1.4× 10 672
Shunjie Xia China 9 534 1.2× 399 1.1× 86 0.4× 98 0.6× 67 0.7× 13 731
Zhangqian Chen China 14 700 1.6× 421 1.2× 227 1.2× 115 0.6× 50 0.5× 19 961
Hong Shen China 10 312 0.7× 168 0.5× 203 1.1× 151 0.9× 69 0.7× 16 630

Countries citing papers authored by Tingdong Yu

Since Specialization
Citations

This map shows the geographic impact of Tingdong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tingdong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tingdong Yu more than expected).

Fields of papers citing papers by Tingdong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tingdong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tingdong Yu. The network helps show where Tingdong Yu may publish in the future.

Co-authorship network of co-authors of Tingdong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Tingdong Yu. A scholar is included among the top collaborators of Tingdong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tingdong Yu. Tingdong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shaojun, et al.. (2025). FCGR2A contributes to M2 macrophages polarization in HCC through IL-4/JAK/STAT6 axis. Translational Oncology. 58. 102429–102429.
2.
Zhang, Siyu, et al.. (2024). circ_HMGCS1 modulates hepatocellular carcinoma chemoresistance via miR‐338‐5p/IL‐7 pathway. Journal of Cellular and Molecular Medicine. 28(6). e18137–e18137. 3 indexed citations
3.
Yu, Tingdong, et al.. (2024). Application of integrin subunit genes in pancreatic cancer and the construction of a prognosis model. Journal of Gastrointestinal Oncology. 15(5). 2286–2304.
4.
Liu, Xin, et al.. (2024). The EFNA4 gene is a potential prognostic biomarker in pancreatic cancer: a bioinformatics analysis. Journal of Gastrointestinal Oncology. 15(3). 1165–1178.
5.
6.
Lei, Yujie, Yunchao Huang, Guangqiang Zhao, et al.. (2023). Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma. BMC Cancer. 23(1). 1141–1141. 2 indexed citations
7.
Fang, Dalang, Shuqi Zhao, Tingdong Yu, et al.. (2022). Down regulated oncogene KIF2C inhibits growth, invasion, and metastasis of hepatocellular carcinoma through the Ras/MAPK signaling pathway and epithelial-to-mesenchymal transition. Annals of Translational Medicine. 10(3). 151–151. 24 indexed citations
8.
Yu, Tingdong, Yanan He, Haitao Chen, et al.. (2022). Polysaccharide from Echinacea purpurea plant ameliorates oxidative stress-induced liver injury by promoting Parkin-dependent autophagy. Phytomedicine. 104. 154311–154311. 18 indexed citations
9.
Yu, Tingdong, Xinping Ye, Wen Zhang, et al.. (2021). Intraoperative Indocyanine Green Retention Test of Left Hemiliver in Decision-Making for Patients With Hepatocellular Carcinoma Undergoing Right Hepatectomy. Frontiers in Surgery. 8. 709017–709017. 2 indexed citations
10.
11.
Han, Chuangye, Tingdong Yu, Wei Qin, et al.. (2020). Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus. Journal of Gastrointestinal Oncology. 11(6). 1333–1349. 18 indexed citations
12.
Wang, Xiangkun, Xiwen Liao, Ketuan Huang, et al.. (2019). Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma. Journal of Cancer. 10(11). 2520–2533. 37 indexed citations
13.
Yang, Chengkun, Ketuan Huang, Xiangkun Wang, et al.. (2019). Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 9. 511–511. 25 indexed citations
14.
Wang, Xiangkun, Xiwen Liao, Chengkun Yang, et al.. (2019). Diagnostic and prognostic biomarkers of Human Leukocyte Antigen complex for hepatitis B virus-related hepatocellular carcinoma. Journal of Cancer. 10(21). 5173–5190. 11 indexed citations
15.
Liao, Xiwen, Xiaoguang Liu, Chengkun Yang, et al.. (2018). Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma. Journal of Cancer. 9(13). 2357–2373. 52 indexed citations
16.
Liao, Xiwen, Xiangkun Wang, Ketuan Huang, et al.. (2018). Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy. Cancer Management and Research. Volume 10. 2537–2551. 23 indexed citations
17.
Liao, Xiwen, Chuangye Han, Xiangkun Wang, et al.. (2018). Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy. Cancer Management and Research. Volume 10. 3255–3271. 22 indexed citations
18.
Liao, Xiwen, Guangzhi Zhu, Rui Huang, et al.. (2018). Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma. Cancer Management and Research. Volume 10. 787–803. 35 indexed citations
19.
Yu, Tingdong, Xiangkun Wang, Guangzhi Zhu, et al.. (2018). The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma. Cancer Management and Research. Volume 10. 1713–1726. 25 indexed citations
20.
Liao, Xiwen, Chengkun Yang, Rui Huang, et al.. (2018). Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma. Cellular Physiology and Biochemistry. 48(5). 1854–1869. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengguang Yuan Breakdown of academic impact, for papers by Romain Riscal Breakdown of academic impact, for papers by Xiaoliang Xu Breakdown of academic impact, for papers by Danyu Du Breakdown of academic impact, for papers by Dinghua Yang Breakdown of academic impact, for papers by Jiangting Hu Breakdown of academic impact, for papers by Antoine L’Hermitte Breakdown of academic impact, for papers by Shunjie Xia Breakdown of academic impact, for papers by Zhangqian Chen Breakdown of academic impact, for papers by Hong Shen
Rankless by CCL
2026